Pharmaceutical Filtration Market

The global pharmaceutical filtration market is projected to reach USD 21.75 billion by 2030 from USD 14.35 billion in 2025, registering a CAGR of 8.7% between 2025 and 2030. The growth of the pharmaceutical filtration market is attributed to major factors such as the growing development and commercialization of biologics and biosimilars, and tightening global regulatory expectations for sterility and viral safety.

Several key players in the pharmaceutical filtration industry with a strong global footprint include Merck KGaA (Germany) Danaher Corporation (US), Sartorius AG (Germany), Solventum (US), Parker Hannifin Corporation (US), Thermo Fisher Scientific Inc. (US), Eaton Corporation plc (Ireland), Repligen Corporation (US), Donaldson Company, Inc. (US), Porvair PLC (UK), Alfa Laval Corporate AB (Sweden), Corning Incorporated (US), MANN+HUMMEL (Germany), among others. Companies operating in this sector are employing various growth strategies to strengthen their international presence and reinforce market positions. For instance, Parker Hannifin, Solventum, and Donaldson enhance their competitive positioning through targeted acquisitions and the expansion of advanced filtration technologies into sterile processing, contamination control, and upstream bioprocessing. At the same time, Thermo Fisher Scientific and Danaher continue to broaden capabilities through end-to-end bioprocessing platforms that integrate filtration with analytics, purification, and quality assurance systems.

To know about the assumptions considered for the study download the pdf brochure

In June 2025, Cytiva set up new filtration manufacturing lines in Pensacola, Florida, aiming to boost North American filter membrane production capacity by 20%. In September 2025, Thermo Fisher Scientific acquired the Purification and Filtration Business of Solventum.

Merck KGaA (Germany)

Merck KGaA (Germany) reinforced its leadership in the global pharmaceutical filtration market by delivering high-performance solutions tailored for biologics, vaccines, and advanced therapeutics. Its Millipore Express membranes, Mobius single-use assemblies, and Stericup/Steritop systems enhance sterility assurance, streamline workflows, and reduce contamination risks. The company focuses on improving manufacturing efficiency and regulatory compliance through robust, scalable filtration technologies. Merck further expanded its global production capabilities with major facility investments in Darmstadt and Cork to meet rising demand for high-throughput filtration used in mAbs, cell and gene therapies, and next-generation vaccine manufacturing.

Danaher Corporation (US)

Danaher solidified its position as a major force in the pharmaceutical filtration market through its bioprocessing powerhouse brands, including Cytiva and Pall. The company delivers advanced filtration membranes, depth filters, and fully integrated single-use systems that support biologics, vaccines, and cell therapy production. Danaher emphasizes process reliability, contamination control, and scalability, enabling manufacturers to achieve consistent, high-quality outputs. Ongoing investments in global manufacturing capacity, such as expansions across Cytiva’s filtration facilities, aim to meet the growing demand for high-throughput, end-to-end filtration solutions in next-generation biomanufacturing.

Sartorius AG (Germany)

Sartorius AG is a leading player in the pharmaceutical filtration market, recognized for its broad bioprocessing and lab filtration portfolio that supports drug development and commercial biologics production worldwide. The company focuses on integrated single-use solutions, advanced membranes, and depth filtration systems that enable efficient, scalable, and compliant biomanufacturing for vaccines, monoclonal antibodies (mAbs), cell & gene therapies, and emerging modalities such as exosomes.

Market Ranking

The pharmaceutical filtration market is characterized by significant consolidation, with leading players controlling a substantial share of global revenues, estimated at around 55% to 60% of the total market. These major companies reinforce their positions through strategic acquisitions, advanced manufacturing capabilities, and extensive distribution networks. Merck KGaA (Germany) is a leading innovator in pharmaceutical filtration, offering high-performance membrane systems, single-use assemblies, and sterile filtration solutions that support biologics, vaccines, and cell and gene therapy manufacturing. Danaher (US), through its Cytiva and Pall brands, delivers integrated depth filtration, sterilizing-grade membranes, and single-use platforms that enable scalable, contamination-free bioprocessing. Sartorius (Germany) focuses on advanced biopharmaceutical filtration technologies, including optimized membrane filters, process-scale systems, and modular single-use setups that enhance efficiency and regulatory compliance. Solventum (US) strengthens global filtration operations with novel depth media, bacterial retention filters, and contamination-control technologies for sterile drug production. Parker Hannifin (US) expands its presence through high-purity filtration, gas-liquid separation systems, and process protection filters designed for reliable upstream and downstream pharmaceutical workflows.

The pharmaceutical filtration market is advancing rapidly with investments in high-purity membrane technologies, single-use filtration systems, automated process controls, and integrated bioprocessing platforms. Growth is driven by the rising demand for biologics, cell and gene therapies, and high-value sterile drugs, alongside stringent regulatory requirements for contamination control and product safety. The remainder of the market, accounting for approximately 45–40%, comprises regional filtration suppliers and niche technology developers. These players are expanding through targeted innovation, localized partnerships, and customized filtration solutions tailored to small-scale biomanufacturers, emerging therapy developers, and facilities requiring flexible, application-specific filtration capabilities.

Related Reports:

Pharmaceutical Filtration Market by Product (Membrane filter, Depth filter, Virus filter, Air Filter, Assemblies, Systems (Single-use)), Technique (Ultrafiltration), Type (Sterile), Application (API, Protein), Scale, End User - Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com